Beta-hydroxy-beta-methylbutyrate (HMB) is a leucine metabolite with protein anabolic effects. We examined the effects of an HMB-enriched diet in healthy rats and rats with liver cirrhosis induced by multiple doses of carbon tetrachloride (CCl4). HMB increased branched-chain amino acids (BCAAs; valine, leucine and isoleucine) in blood and BCAA and ATP in muscles of healthy animals. The effect on muscle mass and protein content was insignificant. In CCl4-treated animals alterations characteristic of liver cirrhosis were found with decreased ratio of the BCAA to aromatic amino acids in blood and lower muscle mass and ATP content when compared with controls. In CCl4-treated animals consuming HMB, we observed higher mortality, lower body weight, higher BCAA levels in blood plasma, higher ATP content in muscles, and lower ATP content and higher cathepsin B and L activities in the liver when compared with CCl4-treated animals without HMB. We conclude that (1) HMB supplementation has a positive effect on muscle mitochondrial function and enhances BCAA concentrations in healthy animals and (2) the effects of HMB on the course of liver cirrhosis in CCl4-treated rats are detrimental. Further studies examining the effects of HMB in other models of hepatic injury are needed to determine pros and cons of HMB in the treatment of subjects with liver cirrhosis.

Department of Physiology Faculty of Medicine in Hradec Kralove Charles University Hradec Kralove Czech Republic

Zobrazit více v PubMed

Pinheiro CH, Gerlinger‐Romero F, Guimarães‐Ferreira L, et al. Metabolic and functional effects of beta‐hydroxy‐beta‐methylbutyrate (HMB) supplementation in skeletal muscle. Eur J Appl Physiol. 2012;112:2531‐2537. PubMed

He X, Duan Y, Yao K, et al. β‐Hydroxy‐β‐methylbutyrate, mitochondrial biogenesis, and skeletal muscle health. Amino Acids. 2016;48:653‐664. PubMed

Kovarik M, Muthny T, Sispera L, et al. Effects of β‐hydroxy‐β‐methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J Physiol Biochem. 2010;66:311‐319. PubMed

Girón MD, Vílchez JD, Salto R, et al. Conversion of leucine to β‐hydroxy‐β‐methylbutyrate by α‐keto isocaproate dioxygenase is required for a potent stimulation of protein synthesis in L6 rat myotubes. J Cachexia Sarcopenia Muscle. 2016;7:68‐78. PubMed PMC

Vallejo J, Spence M, Cheng AL, et al. Cellular and physiological effects of dietary supplementation with β‐hydroxy‐β‐methylbutyrate (HMB) and β‐alanine in late middle‐aged mice. PLoS ONE. 2016;11(3):e0150066. PubMed PMC

Clark RH, Feleke G, Din M, et al. Nutritional treatment for acquired immunodeficiency virus‐associated wasting using beta‐hydroxy beta‐methylbutyrate, glutamine, and arginine: a randomized, double‐blind, placebo‐controlled study. JPEN J Parenter Enteral Nutr. 2000;24:133‐139. PubMed

Ekinci O, Yanık S, Terzioğlu Bebitoğlu B, et al. Effect of calcium β‐hydroxy‐β‐methylbutyrate (CaHMB), vitamin D, and protein supplementation on postoperative immobilization in malnourished older adult patients with hip fracture: a randomized controlled study. Nutr Clin Pract. 2016;31:829‐835. PubMed

Olveira G, Olveira C, Doña E, et al. Oral supplement enriched in HMB combined with pulmonary rehabilitation improves body composition and health related quality of life in patients with bronchiectasis (Prospective, Randomised Study). Clin Nutr. 2016;35:1015‐2102. PubMed

Rathmacher JA, Nissen S, Panton L, et al. Supplementation with a combination of beta‐hydroxy‐beta‐methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J Parenter Enteral Nutr. 2004;28:65‐75. PubMed

Holeček M. Beta‐hydroxy‐beta‐methylbutyrate supplementation and skeletal muscle in healthy and muscle‐wasting conditions. J Cachexia Sarcopenia Muscle. 2017;8:529‐541. PubMed PMC

Dasarathy S, Hatzoglou M. Hyperammonemia and proteostasis in cirrhosis. Curr Opin Clin Nutr Metab Care. 2018;21:30‐36. PubMed PMC

Holeček M, Vodeničarovová M. Effects of beta‐hydroxy‐beta‐methylbutyrate in partially hepatectomized rats. Physiol Res. 2018;67:741‐751. PubMed

Holecek M, Muthny T, Kovarik M, et al. Effect of beta‐hydroxy‐beta‐methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food Chem Toxicol. 2009;47:255‐259. PubMed

Fischer JE, Funovics JM, Aguirre A, et al. The role of plasma amino acids in hepatic encephalopathy. Surgery. 1975;78:276‐290. PubMed

Holecek M. Three targets of branched‐chain amino acid supplementation in the treatment of liver disease. Nutrition. 2010;26:482‐490. PubMed

Holeček M, Mráz J, Tilšer I. Plasma amino acids in four models of experimental liver injury in rats. Amino Acids. 1996;10:229‐241. PubMed

Holeček M, Vodeničarovová M. Muscle wasting and branched‐chain amino acid, alpha‐ketoglutarate, and ATP depletion in a rat model of liver cirrhosis. Int J Exp Pathol. 2018;99:274‐281. PubMed PMC

Kadlcikova J, Holecek M, Safranek R, et al. Effects of proteasome inhibitors MG132, ZL3VS and AdaAhx3L3VS on protein metabolism in septic rats. Int J Exp Pathol. 2004;85:365‐371. PubMed PMC

Holeček M, Mičuda S. Amino acid concentrations and protein metabolism of two types of rat skeletal muscle in postprandial state and after brief starvation. Physiol Res. 2017;66:959‐967. PubMed

Holecek M, Skopec F, Sprongl L. Protein metabolism in cirrhotic rats: effect of dietary restriction. Ann Nutr Metab. 1995;39:346‐354. PubMed

Gomes‐Marcondes MC, Tisdale MJ. Induction of protein catabolism and the ubiquitin‐proteasome pathway by mild oxidative stress. Cancer Lett. 2002;180:69‐74. PubMed

Koohmaraie M, Kretchmar DH. Comparisons of four methods for quantification of lysosomal cysteine proteinase activities. J Anim Sci. 1990;68:2362‐2370. PubMed

Holecek M, Kovarik M. Alterations in protein metabolism and amino acid concentrations in rats fed by a high‐protein (casein‐enriched) diet ‐ effect of starvation. Food Chem Toxicol. 2011;49:3336‐3342. PubMed

Vodenicarovova M, Skalska H, Holecek M. Deproteinization is necessary for the accurate determination of ammonia levels by glutamate dehydrogenase assay in blood plasma from subjects with liver injury. Lab. Med. 2017;48:339‐345. PubMed

Nissen SL, Abumrad NN. Nutritional role of the leucine metabolite β‐hydroxy‐β‐methylbutyrate (HMB). J Nutr Biochem. 1997;8:300‐311.

Holecek M. Branched‐chain amino acids and ammonia metabolism in liver disease: therapeutic implications. Nutrition. 2013;29:1186‐1191. PubMed

Holecek M. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy‐therapeutic perspectives. Metab Brain Dis. 2014;29:9‐17. PubMed PMC

Nishikawa T, Bellance N, Damm A, et al. A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol. 2014;60:1203‐1211. PubMed PMC

Yonamine CY, Teixeira SS, Campello RS, et al. Beta hydroxy beta methylbutyrate supplementation impairs peripheral insulin sensitivity in healthy sedentary Wistar rats. Acta Physiol (Oxf). 2014;212:62‐74. PubMed

Holeček M. Branched‐chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements. Nutr Metab (Lond). 2018;15:33. PubMed PMC

Wijekoon EP, Skinner C, Brosnan ME, et al. Amino acid metabolism in the Zucker diabetic fatty rat: effects of insulin resistance and of type 2 diabetes. Can J Physiol Pharmacol. 2004;82:506‐514. PubMed